MedpageToday

8 articles in the TruthFoundry index. Each links out to the original.

• Study Links Menopause Testosterone Therapy To Elevated Heart Risk · Retrospective study finds higher cardiovascular risk in postmenopausal women using testosterone.
• Study Suggests Most Lab Tests Do Not Require 8-Hour Fasting · A study of over 100,000 patients suggests most blood tests do not require 8 hours of fasting, with glucose being a key exception.
• ADA Boycott Follows Meeting Scandal; Lawsuits Fly in Residency Application Space · Healthcare leaders boycott the American Diabetes Association after a meeting incident, while two lawsuits challenge residency application monopolies.
• Healthcare Consolidation Forces Patients to More Expensive Treatment Venues · Vertical integration in healthcare is driving patients to higher-cost settings despite professional recommendations for lower-cost options.
• ADA Concludes Review of Meeting Disruptions; Attendees Cited Code Violations · The American Diabetes Association concluded its review of June meeting disruptions, citing code violations for five removed attendees.
• FDA Expands Mounjaro Label; T1D Cases Projected to Rise · FDA approved Mounjaro for cardiovascular risk reduction in type 2 diabetes as global type 1 diabetes cases are projected to rise.
• GLP-1 Drugs Linked to Lower TB and Infection Risks in Diabetes Patients · New studies indicate GLP-1 medications reduce tuberculosis and serious infection risks in people with type 2 diabetes.
• Thyroid Meds Recalled; Life Expectancy Rebounds; Cannabis Use Hits Record · Vitruvias Therapeutics recalls thyroid meds; US life expectancy surpasses pre-pandemic levels; marijuana use hits record high.